Orgenesis Inc (ORGS)
0.5072
+0.01
(+1.26%)
USD |
NASDAQ |
Apr 22, 16:00
0.5136
+0.01
(+1.26%)
Pre-Market: 20:00
Orgenesis Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -11.50K% |
| June 30, 2023 | -59.17% |
| March 31, 2023 | -13.71K% |
| December 31, 2022 | -30.07% |
| September 30, 2022 | -16.98% |
| June 30, 2022 | -75.36% |
| March 31, 2022 | -55.59% |
| December 31, 2021 | -72.78% |
| September 30, 2021 | -117.1% |
| June 30, 2021 | -25.22% |
| March 31, 2021 | -2.33% |
| December 31, 2020 | -2.01K% |
| September 30, 2020 | -140.4% |
| June 30, 2020 | -1.17K% |
| March 31, 2020 | |
| December 31, 2019 | 29.88% |
| September 30, 2019 | -49.87% |
| Date | Value |
|---|---|
| June 30, 2019 | -459.9% |
| March 31, 2019 | -113.8% |
| November 30, 2018 | -86.11% |
| August 31, 2018 | -81.38% |
| May 31, 2018 | -65.56% |
| February 28, 2018 | -212.9% |
| November 30, 2017 | 5.63% |
| August 31, 2017 | -153.8% |
| May 31, 2017 | -108.3% |
| February 28, 2017 | -330.8% |
| November 30, 2016 | -253.2% |
| August 31, 2016 | -143.0% |
| May 31, 2016 | -343.8% |
| February 29, 2016 | 14.80% |
| November 30, 2015 | -78.72% |
| August 31, 2015 | -172.5% |
| May 31, 2015 | -133.8% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-13.71K%
Minimum
Mar 2023
29.88%
Maximum
Dec 2019
-1.73K%
Average
-72.78%
Median
Dec 2021
Profit Margin (Quarterly) Benchmarks
| Altimmune Inc | -85.52K% |
| Verastem Inc | -- |
| Oragenics Inc | -- |
| Actinium Pharmaceuticals Inc | -11.51K% |
| Dare Bioscience Inc | -279.8% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -263.7% |
| Return on Assets | -118.2% |
| Return on Invested Capital | -150.1% |
| Return on Net Operating Assets | -156.1% |